SEK5.25 0.0 0.0%
Last Trade - 11/11/20
| Market Cap | ÂŁ7.54m |
| Enterprise Value | ÂŁ6.45m |
| Revenue | ÂŁ1.62k |
| Position in Universe | th / 1874 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.17 | 0.006 | 0.003 | 0.000 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Aptahem AB is a manufacturer of biological products. The company was founded in 2014 and is located in Malmo, Sweden.
| Last Annual | December 31st, 2019 |
| Last Interim | September 30th, 2020 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Healthcare |
| Industry | Biotechnology & Medical Research |
| Index | |
| Exchange | AktieTorget Stock Exchange (Dual Listing) |
| Shares in Issue | 65,859,072 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Norra Vallgatan 58 4Tr, MALMO, 211 22, Sweden |
| Web | |
| Phone | + |
| Auditors | Tornseglet AB |
As of 11/11/20, shares in Aptahem AB are trading at SEK5.25, giving the company a market capitalisation of ÂŁ7.54m. This share price information is delayed by 15 minutes.
Shares in Aptahem AB are currently trading at SEK5.25 and the price has moved by 0.129k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Aptahem AB price has moved by 0.111k% over the past year.
There are no analysts currently covering Aptahem AB.
Aptahem AB is scheduled to issue upcoming financial results on the following dates:
Aptahem AB does not currently pay a dividend.
Aptahem AB does not currently pay a dividend.
Aptahem AB does not currently pay a dividend.
To buy shares in Aptahem AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Aptahem AB are currently trading at SEK5.25, giving the company a market capitalisation of ÂŁ7.54m.
Here are the trading details for Aptahem AB:
We were not able to load our ranking data for Aptahem AB
We were not able to load any forecast data for Aptahem AB.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aptahem AB. Over the past six months, the relative strength of its shares against the market has been 0.105k%. At the current price of SEK5.25, shares in Aptahem AB are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Aptahem AB.
We were unable to find the directors for Aptahem AB.
Here are the top five shareholders of Aptahem AB based on the size of their shareholding:
